Literature DB >> 12360906

ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists.

.   

Abstract

Recurrent pregnancy loss is a common clinical problem in reproduction, occurring in approximately 1% of reproductive-aged women. A definite cause is established in no more than 50% of couples, and several alleged causes of recurrent pregnancy loss are controversial. Moreover, in the field of recurrent pregnancy loss, inappropriate emphasis often is given to unproven hypotheses and poorly designed clinical studies. Seeking a solution, some patients and physicians explore less-well-accepted etiologies and empirical or alternative treatments. This bulletin will provide the practitioner with a rational, modern approach to the management of recurrent pregnancy loss. New and controversial etiologies will be presented so that the practitioner can discuss them with couples who have a history of recurrent pregnancy loss.

Entities:  

Mesh:

Year:  2002        PMID: 12360906     DOI: 10.1016/s0020-7292(02)00197-2

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  40 in total

1.  Autoimmunity: effectiveness of treatments for pregnant women with APS.

Authors:  Shari E Gelber; Jane E Salmon
Journal:  Nat Rev Rheumatol       Date:  2010-04       Impact factor: 20.543

2.  Investigation of recurrent miscarriages.

Authors:  Fred Kavalier
Journal:  BMJ       Date:  2005-07-16

3.  Selective chromosome analysis in couples with two or more miscarriages: case-control study.

Authors:  Maureen T M Franssen; Johanna C Korevaar; Nico J Leschot; Patrick M M Bossuyt; Alida C Knegt; Klasien B J Gerssen-Schoorl; Cokkie H Wouters; Kerstin B M Hansson; Ron Hochstenbach; Kamlesh Madan; Fulco van der Veen; Mariette Goddijn
Journal:  BMJ       Date:  2005-06-28

4.  Dialkyl phosphate urinary metabolites and chromosomal abnormalities in human sperm.

Authors:  Zaida I Figueroa; Heather A Young; John D Meeker; Sheena E Martenies; Dana Boyd Barr; George Gray; Melissa J Perry
Journal:  Environ Res       Date:  2015-10-28       Impact factor: 6.498

5.  Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).

Authors:  B Toth; W Würfel; M K Bohlmann; G Gillessen-Kaesbach; F Nawroth; N Rogenhofer; C Tempfer; T Wischmann; M von Wolff
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

6.  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

Authors:  Sarah A Mbaeyi; Catherine H Bozio; Jonathan Duffy; Lorry G Rubin; Susan Hariri; David S Stephens; Jessica R MacNeil
Journal:  MMWR Recomm Rep       Date:  2020-09-25

7.  Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.

Authors:  Mercy Y Laurino; Robin L Bennett; Devki S Saraiya; Lisa Baumeister; Debra Lochner Doyle; Kathleen Leppig; Barbara Pettersen; Robert Resta; Larry Shields; Stefanie Uhrich; Elizabeth A Varga; Wendy H Raskind
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

8.  The clinical content of preconception care: genetics and genomics.

Authors:  Benjamin D Solomon; Brian W Jack; W Gregory Feero
Journal:  Am J Obstet Gynecol       Date:  2008-12       Impact factor: 8.661

9.  Reproductive outcome after chromosome analysis in couples with two or more miscarriages: index [corrected]-control study.

Authors:  Maureen T M Franssen; Johanna C Korevaar; Fulco van der Veen; Nico J Leschot; Patrick M M Bossuyt; Mariette Goddijn
Journal:  BMJ       Date:  2006-02-22

10.  Presentation and treatment of subfertile men with balanced translocations: the cleveland clinic experience.

Authors:  Christina B Ching; Edmund Ko; Bryan Hecht; Marissa Smith; Edmund Sabanegh
Journal:  Curr Urol       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.